J&J Drug Gets Mixed Panel Vote

A panel of experts deemed Johnson & Johnson’s Doribax safe and effective, but their voting revealed they weren’t too keen on accepting the studies that support the drug’s application for Food and Drug Administration approval.
TheStreet.com